Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 320.20 million as of November 21, 2024. Its market cap has decreased by -53.49% in one year.

Market Cap

320.20M

Enterprise Value

187.34M

Revenue

27.07M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.44

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 320.20M, a decrease of -80.82%. That is a compound annual growth rate of -19.20%.

Market Cap History

Date	Market Cap	% Change
Nov 19, 2024	309.44M	-57.30%
Dec 29, 2023	724.64M	-36.76%
Dec 30, 2022	1.15B	81.18%
Dec 30, 2021	632.45M	-94.51%
Dec 30, 2020	11.53B	63.96%
Dec 30, 2019	7.03B	21.37%
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Feb 22, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca PLC	2,154.31B
Swedish Orphan Biovitrum AB (publ)	103.72B
Sectra AB (publ)	52.88B
Getinge AB (publ)	46.60B
Camurus AB (publ)	32.02B
Vitrolife AB (publ)	29.65B
Medicover AB (publ)	26.06B
Elekta AB (publ)	24.07B

Market Cap Rankings